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Summary
In HCM, LGE defined LV fibrosis is commonplace and
generally not considered in the RV. However, by CMR-
LGE it may be more commonplace than expected.
Background
CMR has become the leading technique to detect hyper-
trophic cardiomyopathy (HCM) providing complete cov-
erage of both ventricles with high spatial resolution.
Late gadolinium enhancement (LGE) accurately identi-
fies regions of myocardial fibrosis. Via CMR, innumer-
able studies have established LVH as the predominant
phenotypic expression. It is well known that myocardial
fibrosis can occur in patients with HCM and is indepen-
dently linked to worse prognosis than those without
fibrosis by CMR. The genotypic expressions would
appear to affect the entire heart yet, conventionally;
descriptions have been limited to the LV, likely due to
the inability to image the smaller, thinner RV. Thus, lit-
tle information is available about the RV in HCM. We
hypothesize there may be RV involvement in HCM
when incorporating CMR analysis for RV hypertrophy
and fibrosis.
Methods
Review of all patients referred for HCM was performed.
SSFP/LGE was used to diagnose patients with HCM,
using gadolinium administration (MultiHance,
0.15mmol/kg, Bracco Diagnostics, Princeton, NJ). Post-
injection LGE images were obtained via T1-weighted, IR
preps. Regions of myocardium with abnormally high sig-
nals (>2SD) were designated as fibrotic. LV/RVMass
Index was calculated.
Results
Via 99 patients referred for HCM from 2006-2011, 28
(28%) were confirmed to be HCM via CMR. Image
quality was judged excellent in 27/28 (97%). The mean
LVMI was 97±40gm2 (> 2SDabove normal) while the
mean RVMI was 22±5 gm2 (>1SD > normal). All
patients met formal LVH criteria while 17/28 (61%) met
RVH criteria. LV fibrosis was evident in 24/28 (86%)
while most, 19/28 (67%), also had evidence for RV fibro-
sis. No patients with RV fibrosis had absent LV fibrosis.
In neither the LV nor RV did the degree of hypertrophy
predict the likelihood for fibrosis (98±38 vs.84±26g/m2
and 22±24 vs.21±25g/m2, respectively).
Conclusions
The high frequency of RV fibrosis in the setting of
HCM is unforeseen presumably as this phenomenon is
not anticipated. However, given the genetic abnormal-
ities, there is no reason to expect the phenotypic expres-
sion should be limited to just the LV. Interestingly,
similar for LVH, the degree of RVH had little predictive
power to define fibrosis.
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